Form4insider filings, from the source

SEC Form 4 · accession 0001127602-19-009264

LEXICON PHARMACEUTICALS, INC. · LXRX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Alexander A Santini
Officer — EVP and CCO
Period of report
Feb 28, 2019
Accepted (ET)
Mar 1, 2019 · 5:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 28, 2019M2,352—A7,649D
Common StockF1Feb 28, 2019M2,593—A10,242D
Common StockF1Feb 28, 2019M8,463—A18,705D
Common StockFeb 28, 2019F4,544$5.51D14,161D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF1,F3—Feb 28, 2019M2,352D——Common Stock2,3522,353D
Restricted Stock UnitsF1,F4—Feb 28, 2019M2,593D——Common Stock2,5935,185D
Restricted Stock UnitsF1,F5—Feb 28, 2019M8,463D——Common Stock8,46316,927D

Explanation of responses